CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Shares withheld for taxes CHIEF PRODUCT OFFICER gave up 334 shares (to pay taxes)
- 4 Planned sale Chief Executive Officer sold 3,832 shares at $140.00 ($536,480)
- 4 Grant or award Senior VP, R&D acquired 5,284 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 24,134 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 7,751 shares (grant or award)
- 4 Grant or award CFO acquired 7,751 shares (grant or award)
- 4 Shares withheld for taxes Chief Operating Officer gave up 62 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 42 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 3,911 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,954 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 9,897 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 1,042 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 1,367 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF PRODUCT OFFICER gave up 221 shares (to pay taxes)
- 4 Grant or award CHIEF PRODUCT OFFICER acquired 2,288 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 275 shares at $161.00 ($44,275)
- 4 Option exercise Director acquired 3,366 shares (option exercise)
- 4 Other disposition Director disposed of 2,000 shares (other)
- 4 Planned sale Chief Executive Officer sold 7,041 shares at $170.00 ($1,196,970)
Page 2 of 34 · 669 filings